Article Information
History
- June 28, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Gunvor Aasbø1,2,*,
- Ameli Tropè3,
- Mari Nygård1,
- Irene Kraus Christiansen4,
- Ingrid Baasland3,5,
- Grete Alrek Iversen6,
- Ane Cecilie Munk7,
- Marit Halonen Christiansen8,
- Gro Kummeneje Presthus4,
- Karina Undem1,9,
- Tone Bjørge3,10,
- Philip E. Castle11,12 and
- Bo Terning Hansen1,13
- 1Department of Research, Cancer Registry of Norway, Oslo, Norway
- 2Institute of Health and Society, University of Oslo, Oslo, Norway
- 3Cervical Cancer Screening Programme, Cancer Registry of Norway, Oslo, Norway
- 4National HPV Reference Laboratory, Department of Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway
- 5Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway
- 6Department of Obstetrics and Gynaecology, Haukeland University Hospital, Bergen, Norway
- 7Department of Obstetrics and Gynaecology, Sørlandet Hospital Kristiansand, Kristiansand, Norway
- 8Department of Obstetrics and Gynaecology, Stavanger University Hospital, Stavanger, Norway
- 9National Institute of Occupational Health, Oslo, Norway
- 10Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway
- 11Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
- 12Divisions of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA
- 13Department of Infection Control and Vaccine, Norwegian Institute of Public Health, Oslo, Norway
- ↵*Corresponding author:
Gunvor Aasbø, PhD, Department of Research, Cancer Registry of Norway, Oslo, Norway. Address: Postboks 5313 Majorstuen, 0304 Oslo, Norway gunvor.aasbo{at}medisin.uio.no, phone: +47 482 57 136